These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 26387089)
1. STAT3 contributes to NK cell recognition by modulating expression of NKG2D ligands in adriamycin-resistant K562/AO2 cells. Cai X; Lu X; Jia Z; Zhang X; Han W; Rong X; Ma L; Zhou M; Chen B Int J Hematol; 2015 Nov; 102(5):536-43. PubMed ID: 26387089 [TBL] [Abstract][Full Text] [Related]
2. [Expression of HLA class I molecules and MHC class I chain-related molecules A/B in K562 and K562/AO2 cell lines and their effects on cytotoxicity of NK cells]. Mei JZ; Niu XQ; Guo KY; Zhou J; Wei HM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):288-91. PubMed ID: 17493333 [TBL] [Abstract][Full Text] [Related]
3. Adipocytes affect castration-resistant prostate cancer cells to develop the resistance to cytotoxic action of NK cells with alterations of PD-L1/NKG2D ligand levels in tumor cells. Xu L; Shen M; Chen X; Zhu R; Yang DR; Tsai Y; Keng PC; Chen Y; Lee SO Prostate; 2018 Apr; 78(5):353-364. PubMed ID: 29330929 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of Myc promotes the evasion of NK cell‑mediated immunity through suppression of NKG2D ligands in K562 cells. Lee YS; Heo W; Son CH; Kang CD; Park YS; Bae J Mol Med Rep; 2019 Oct; 20(4):3301-3307. PubMed ID: 31432134 [TBL] [Abstract][Full Text] [Related]
5. [NKG2D-mediated natural killer cell cytotoxicity against myeloid leukemia cells OUN-1]. Lu XZ; Cai XH; Ma LD; Chen BA Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):444-7. PubMed ID: 22967377 [TBL] [Abstract][Full Text] [Related]
6. An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia. Steinbacher J; Baltz-Ghahremanpour K; Schmiedel BJ; Steinle A; Jung G; Kübler A; André MC; Grosse-Hovest L; Salih HR Int J Cancer; 2015 Mar; 136(5):1073-84. PubMed ID: 25046567 [TBL] [Abstract][Full Text] [Related]
7. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. Bae JH; Kim JY; Kim MJ; Chang SH; Park YS; Son CH; Park SJ; Chung JS; Lee EY; Kim SH; Kang CD J Immunother; 2010 May; 33(4):391-401. PubMed ID: 20386467 [TBL] [Abstract][Full Text] [Related]
8. [Effects of matrine on the expression of NKG2D ligands in leukemia cells]. Ma LD; Lu XZ; Zhu ZC; Jiang LJ; Zhou M; Qian SX; Li JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1429-34. PubMed ID: 24370024 [TBL] [Abstract][Full Text] [Related]
9. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells. Bedel R; Thiery-Vuillemin A; Grandclement C; Balland J; Remy-Martin JP; Kantelip B; Pallandre JR; Pivot X; Ferrand C; Tiberghien P; Borg C Cancer Res; 2011 Mar; 71(5):1615-26. PubMed ID: 21257710 [TBL] [Abstract][Full Text] [Related]
10. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell. Bae DS; Hwang YK; Lee JK Cell Immunol; 2012; 276(1-2):122-7. PubMed ID: 22613008 [TBL] [Abstract][Full Text] [Related]
11. [Mechanism of Anti Apoptosis and Immune Evasion in Drug-Resistant Leukemia Cells Mediated by STAT3]. Jia ZX; Lu XZ; He JY; Cai XH; Qin W; Han WM; Zhou M; Xu W Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1796-1803. PubMed ID: 33283701 [TBL] [Abstract][Full Text] [Related]
12. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909 [TBL] [Abstract][Full Text] [Related]
13. The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line. Zhang YY; Xie KM; Yang GQ; Mu HJ; Yin Y; Zhang B; Xie P Int J Hematol; 2011 Mar; 93(3):361-367. PubMed ID: 21380926 [TBL] [Abstract][Full Text] [Related]
14. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide. Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537 [TBL] [Abstract][Full Text] [Related]
15. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells]. Mei JZ; Guo KY; Wei HM; Song CY Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663 [TBL] [Abstract][Full Text] [Related]
16. Enhanced Th1 and inflammatory mRNA responses upregulate NK cell cytotoxicity and NKG2D ligand expression in human pre-eclamptic placenta and target it for NK cell attack. Vinnars MT; Björk E; Nagaev I; Ottander U; Bremme K; Holmlund U; Sverremark-Ekström E; Mincheva-Nilsson L Am J Reprod Immunol; 2018 Jul; 80(1):e12969. PubMed ID: 29741244 [TBL] [Abstract][Full Text] [Related]
17. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells]. Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338 [TBL] [Abstract][Full Text] [Related]
18. NK cell maturation to CD56(dim) subset associated with high levels of NCRs overrides the inhibitory effect of NKG2A and recovers impaired NK cell cytolytic potential after allogeneic hematopoietic stem cell transplantation. Ghasemzadeh M; Hosseini E; Schwarer AP; Pourfathollah AA Leuk Res; 2016 Apr; 43():58-65. PubMed ID: 26856773 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of CD24(+) ovarian cancer cells to anti-cancer drugs and natural killer cells. Koh J; Lee SB; Park H; Lee HJ; Cho NH; Kim J Biochem Biophys Res Commun; 2012 Oct; 427(2):373-8. PubMed ID: 22995296 [TBL] [Abstract][Full Text] [Related]
20. c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis. Nanbakhsh A; Pochon C; Mallavialle A; Amsellem S; Bourhis JH; Chouaib S Blood; 2014 Jun; 123(23):3585-95. PubMed ID: 24677544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]